arrow
G

Gregor Hasler

University of Freiburg
H指数:51
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Severe antipsychotic-associated gastrointestinal hypomotility: AMSP pharmacovigilance data from 333,175 psychiatric inpatients

严重抗精神病药物相关胃肠道动力低下:来自33,3175名精神科住院患者的AMSP药物警戒数据

2026-09-190
OAAI
Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study

双相障碍情感与社会认知研究中的子领域和相关性测量共识(CAS-BD);来自国际双相障碍学会认知任务研究小组的成果与建议

2026-02-170
OAAI
Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study

儿童在COVID-19大流行前2年的心理健康、应对方式及相关风险因素:全球COH-FIT研究来自12个国家的全国代表性、多波次、横断面研究结果

2025-12-180
OAAI
Predicting Response to Pro-Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force

预测改善认知干预在心境障碍中的反应:国际双相障碍学会靶向认知工作组系统综述

2025-10-130
OAAI
A Data-Driven Decomposition of Anxiety

数据驱动的焦虑分解

2025-09-010
PRE
Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses

感染时期健康和功能的协作结果研究 (coh-fit): 通过多变量和网络分析洞察新型冠状病毒肺炎大流行期间健康和精神卫生的可修改和不可修改的风险和保护因素

2025-01-011
PRE
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force

双相障碍认知障碍或注意缺陷多动障碍症状的既定和非标签ADHD药物疗法的有效性和安全性: ISBD目标认知工作组的系统评价

2024-03-035
OAAI